Multiplexed Diagnostics Market (Technologies: Very High, High, Medium, Low Density Multiplexed Assays & Next-Generation Sequencing; Applications: Infectious Disease Diagnosis, Oncology, Autoimmune Diseases, Cardiac, Allergies and Others) - Global Industry

News provided by

Jun 23, 2014, 11:56 ET

NEW YORK, June 23, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Multiplexed Diagnostics Market (Technologies: Very High, High, Medium, Low Density Multiplexed Assays & Next-Generation Sequencing; Applications: Infectious Disease Diagnosis, Oncology, Autoimmune Diseases, Cardiac, Allergies and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019

This report covers the market analysis of the multiplexed diagnostics technologies namely, very high, high, medium, low density multiplexed assays & next-generation sequencing. This report contains qualitative information about oligonucleotide arrays, phage display, bacterial artificial chromosome arrays, protein arrays, bead-based arrays, antibody arrays, reverse arrays, mass spectrometry, quantitative PCR bead-based and microplate assays and next-generation sequencing. Further this market is also segmented on the basis of several application areas of multiplexed diagnostics, namely, infectious disease diagnosis, oncology, autoimmune diseases, cardiac conditions, allergies and others (Alzheimer's disease, diabetes, kidney toxicity and HIV). The global multiplexed diagnostics market has phenomenally increased the volume and quality of diagnostic procedures by reducing the turnaround time and analyzing multiple analytes in a single cycle and thereby resulting in rapid adoption of such techniques. The stake holders in this market include market players who provide multiplexed diagnostic assay kits, reagents, solutions and systems.

The qualitative details of the market dynamics of the multiplexed diagnostics market such as drivers, restraints and opportunities that influence the current nature and future status of this field are covered under the market overview section of this report. Impact factors such as market attractiveness analysis and Porter's five forces analysis have also been provided in the market overview section of the report in order to give a thorough analysis of the overall competitive scenario in the global multiplexed diagnostics market. The market size and forecast in terms of USD million has been provided in the report for the period 2011 to 2019. This report also includes the overall market growth rate (Compounded Annual Growth Rate) of technologies, applications and geographic market for the period 2013 to 2019, considering 2012 as the base year.

Geographically, the global multiplexed diagnostics market has been categorized into four geographical regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). This section further includes the market size and forecast of the mentioned regional markets for the period 2011 to 2019 along with their growth rates. This report also includes strategic recommendations, which would be useful for the current and future market players to sustain and grow their share in the global multiplexed diagnostics market. This report concludes with the company profiles section which comprises key information about the major players in this market. Some of the key players profiled in this report include Affymetrix, Agilent Technologies, Gen-Probe, Inc., bioMerieux, Life Technologies, Luminex Corporation and Illumina, Inc.

The global multiplexed diagnostics market is segmented as follows:

Multiplexed Diagnostics Market, by Technology

Very high density multiplexed assays
Oligonucleotide Arrays
Phage Display

High Density Multiplexed Assays
Bacterial Artificial Chromosome Arrays
Protein Arrays

Medium Density Multiplexed Assays
Bead-based Arrays
Antibody Arrays
Reverse Arrays
Mass Spectroscopy

Low Density Multiplexed Arrays
Quantitative PCR Bead-based Assays
Microplate Assays

Next-Generation Sequencing

Multiplexed Diagnostics Market, by Application

Infectious Disease Diagnosis
Oncology
Autoimmune diseases
Cardiac
Allergies
Others

Multiplexed Diagnostics Market, by Geography

Overview
North America
Europe
Asia-Pacific
Rest of the World (RoW)

Table of Contents

Chapter 1 Introduction
1.1 Report Description
1.2 Research Methodology
1.3 Market Segmentation: Multiplexed Diagnostics Market
1.4 List of Abbreviations

Chapter 2 Executive Summary

Chapter 3 Multiplexed Diagnostics Market Overview
3.1 Overview – Current Market Scenario and Future Market Trends
3.1.1 Global Multiplexed Assay Market Revenue, 2011 – 2019 (USD Million)
3.2 Drivers
3.2.1 Completion of the Human Genome Project
3.2.2 Increasing Prevalence of Cancer and Infectious Diseases
3.2.3 Multiple Usage
3.2.4 Evolving Regulatory landscape
3.3 Restraints
3.3.1 Costly Equipment
3.3.2 Lack of skilled labour
3.3.3 Lack of Reimbursement Coverage
3.4 Opportunities
3.4.1 Automation of the Multiplexed Diagnostic Instrument
3.4.2 Development Of Generic Platforms
3.5 Porter's Five Force Analysis for the Global Multiplexed Diagnostics Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of New Entrants
3.5.4 Threat of Substitutes
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis of Multiplexed Assay Market, by Geography

Chapter 4 Global Multiplex Assays Market, by Technology
4.1 Overview – Current Market Scenario and Future Market Trends
4.2 Comparative Analysis: Global Multiplexed Diagnostics Market, by Technology, 2012 & 2019 (Value %)
4.3 Very High Density Multiplexed Assays (> 10,000-plex)
4.3.1 Global Very High Density Multiplexed Assays Market Revenue, 2011 – 2019, (USD Million)
4.3.2 Oligonucleotide Arrays
4.3.3 Phage Display
4.4 High Density Multiplexed Assays (500 ? plex ? 10,000)
4.4.1 Global High Density Multiplexed Assays Market Revenue, 2011 – 2019, (USD Million)
4.4.2 Bacterial Artificial Chromosome Arrays
4.4.3 Protein Arrays
4.5 Medium Density Multiplexed Assays (plex < 500)
4.5.1 Global Medium Density Multiplexed Assays Market Revenue, 2011 – 2019 (USD Million)
4.5.2 Bead-based Arrays
4.5.3 Antibody Arrays
4.5.4 Reverse Arrays
4.5.5 Mass Spectrometry
4.6 Low Density Multiplexed Assays (plex ? 5)
4.6.1 Global Low Density Multiplexed Assays Market Revenue, 2011 – 2019, (USD Million)
4.6.2 Quantitative PCR Bead-based
4.6.3 Microplate Assays
4.7 Next-Generation Sequencing Assays
4.7.1 Global Next Generation Sequencing Market Revenue, 2011 – 2019, (USD Million)

Chapter 5 Global Multiplex Diagnostics Market, By Application
5.1 Overview – Current Market Scenario and Future Market Trends
5.1.1 Comparative Analysis: Global Multiplexed Diagnostics Market, by Application, 2012 & 2019 (Value %)
5.2 Infectious Disease Diagnosis
5.2.1 Global Multiplexed Infectious Disease Diagnostics Market Revenue, 2011 – 2019, (USD Million)
5.3 Oncology
5.3.1 Global Multiplexed Oncology Diagnostics Market Revenue, 2011 – 2019, (USD Million)
5.4 Autoimmune diseases
5.4.1 Global Multiplexed Autoimmune Disease Diagnostics Market Revenue, 2011 – 2019, (USD Million)
5.5 Cardiac
5.5.1 Global Multiplexed Cardiac Diagnostics Market Revenue, 2011 – 2019, (USD Million)
5.6 Allergies
5.6.1 Global Multiplexed Allergy Diagnostics Market Revenue, 2011 – 2019, (USD Million)
5.7 Others
5.7.1 Global Other Multiplexed Diagnostic Applications Market Revenue, 2011 – 2019, (USD Million)

Chapter 6 Global Multiplexed Diagnostics Market, by Geography
6.1 Introduction
6.1.1 Comparative Analysis: Global Multiplexed Diagnostics Market, by Geography (Value %)
6.2 North America
6.2.1 North America Multiplexed Diagnostics Market Revenue, 2011 – 2019 (USD Million)
6.3 Europe
6.3.1 Europe Multiplexed Diagnostics Market Revenue, 2011 – 2019 (USD Million)
6.4 Asia-Pacific
6.4.1 Asia-Pacific Multiplexed Diagnostics Market Revenue, 2011 – 2019 (USD Million)
6.5 Rest of the World (RoW)
6.5.1 Rest of the World (RoW) Multiplexed Diagnostics Market Revenue, 2011 – 2019 (USD Million)

Chapter 7 Recommendations
7.1 Market Strategies for Success
7.1.1 Innovation in Technology
7.1.2 Investing in Emerging Economies

Chapter 8 Company Profiles
8.1 Affymetrix, Inc.
8.1.1 Company Overview
8.1.2 Financial Overview
8.1.3 Product Portfolio
8.1.4 Business Strategies
8.1.4.1 Diversified Product Portfolio
8.1.4.2 Partnerships
8.1.5 Recent Developments
8.2 Agilent Technologies, Inc.
8.2.1 Company Overview
8.2.2 Financial Overview
8.2.3 Product Portfolio
8.2.4 Business Strategies
8.2.4.1 Acquisitions
8.2.4.2 Expansion into Emerging Markets
8.2.5 Recent Developments
8.3 bioMerieux, Inc.
8.3.1 Company Overview
8.3.2 Financial Overview
8.3.3 Product Portfolio
8.3.4 Business Strategies
8.3.4.1 Acquisitions
8.3.4.2 Expansion
8.3.4.3 Partnerships and Collaborations
8.3.5 Recent Developments
8.4 Bio-Rad Laboratories, Inc.
8.4.1 Company Overview
8.4.2 Financial Overview
8.4.3 Product Portfolio
8.4.4 Business Strategies
8.4.4.1 Mergers and Acquisitions
8.4.4.2 Partnership
8.4.5 Recent Developments
8.5 Illumina, Inc.
8.5.1 Company Overview
8.5.2 Financial Overview
8.5.3 Product Portfolio
8.5.4 Business Strategies
8.5.4.1 Strategic Acquisitions
8.5.4.2 Expansion
8.5.4.3 Partnership
8.5.5 Recent Developments
8.6 F. Hoffman-La Roche, Ltd.
8.6.1 Company Overview
8.6.2 Financial Overview
8.6.3 Product Portfolio
8.6.4 Business Strategies
8.6.5 Recent Developments
8.7 Gen-Probe, Inc.
8.7.1 Company Overview
8.7.2 Financial Overview
8.7.3 Product Portfolio
8.7.4 Business Strategies
8.7.4.1 Expansion
8.7.5 Recent Developments
8.8 Life Technologies Corporation
8.8.1 Company Overview
8.8.2 Financial Overview
8.8.3 Business Strategies
8.8.3.1 Partnerships and Collaborations
8.8.4 Recent Developments
8.9 Luminex Corporation
8.9.1 Company Overview
8.9.2 Financial Overview
8.9.3 Product Portfolio
8.9.4 Business Strategies
8.9.4.1 Diversified Product Portfolio
8.9.4.2 Partnerships
8.9.5 Recent Developments
8.10 Seegene, Inc.
8.10.1 Company Overview
8.10.2 Financial Overview
8.10.3 Product Portfolio
8.10.4 Business Strategies
8.10.5 Recent Developments

List of Figures

FIG. 1 Multiplexed Diagnostics Market Segmentation
FIG. 2 Global Multiplexed Diagnostics Market Revenue, by Technology, 2012 (USD Million)
FIG. 3 Global Multiplexed Diagnostics Market Revenue, by Geography, 2012 (USD Million)
FIG. 4 Global Multiplexed Diagnostics Market Revenue, 2011 - 2019 (USD Million)
FIG. 5 Porter's Five Force Analysis: Global Multiplexed Diagnostics Market
FIG. 6 Market Attractiveness Analysis of Global Multiplexed Diagnostics Market, by Geography
FIG. 7 Comparative Analysis: Global Multiplexed Diagnostics Market, by Technology, 2012 & 2019 (Value %)
FIG. 8 Global Very High Density Multiplexed Assays Market Revenue, 2011 – 2019 (USD Million)
FIG. 9 Global High Density Multiplexed Assays Market Revenue, 2011 – 2019 (USD Million)
FIG. 10 Global Medium Density Multiplexed Assays Market Revenue, 2011 – 2019 (USD Million)
FIG. 11 Global Low Density Multiplexed Assays Market Revenue, 2011 – 2019 (USD Million)
FIG. 12 Global Next Generation Sequencing Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Comparative Analysis: Global Multiplexed Diagnostics Market, by Application, 2012 & 2019 (Value %)
FIG. 14 Global Multiplexed Infectious Disease Diagnostics Market Revenue, 2011 – 2019 (USD Million)
FIG. 15 Global Multiplexed Oncology Diagnostics Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 Global Multiplexed Autoimmune Disease Diagnostics Market Revenue, 2011 – 2019 (USD Million)
FIG. 17 Global Multiplexed Cardiac Diagnostics Market Revenue, 2011 – 2019 (USD Million)
FIG. 18 Global Multiplexed Allergy Diagnostics Market Revenue, 2011 – 2019 (USD Million)
FIG. 19 Global Other Multiplexed Diagnostic Applications Market Revenue, 2011 – 2019 (USD Million)
FIG. 20 Comparative Analysis: Global Multiplexed Diagnostics Market, by Geography (Value %)
FIG. 21 North America Multiplexed Diagnostics Market Revenue, 2011 - 2019 (USD Million)
FIG. 22 Europe Multiplexed Diagnostics Market Revenue, 2011 - 2019 (USD Million)
FIG. 23 Asia-Pacific Multiplexed Diagnostics Market Revenue, 2011 – 2019 (USD Million)
FIG. 24 Rest of the World (RoW) Multiplexed Diagnostics Market Revenue, 2011 - 2019 (USD Million)
FIG. 25 Affymetrix, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 26 Agilent Technologies, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 27 bioMerieux, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 28 Bio-Rad Laboratories, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 29 Illumina, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 30 F. Hoffman-La Roche, Ltd.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 31 Gen-Probe, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 32 Life Technologies Corporation, Annual Revenue, 2010 – 2012 (USD Million)
FIG. 33 Luminex Corporation: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 34 Seegene, Inc.: Annual Revenue, 2010 – 2012 (USD Million)

List of Tables

TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Multiplexed Diagnostics Market
TABLE 3 Global Multiplexed Diagnostics Market Revenue, by Technology 2011 – 2019 (USD Million)
TABLE 4 Global Multiplexed Diagnostics Market Revenue, by Application, 2011 – 2019 (USD Million)
TABLE 5 Global Multiplexed Diagnostics Market Revenue, by Geography, 2011 – 2019 (USD Million)

To order this report: Multiplexed Diagnostics Market (Technologies: Very High, High, Medium, Low Density Multiplexed Assays & Next-Generation Sequencing; Applications: Infectious Disease Diagnosis, Oncology, Autoimmune Diseases, Cardiac, Allergies and Others) - Global Industry
http://www.reportlinker.com/p02056530/Multiplexed-Diagnostics-Market-Technologies-Very-High-High-Medium-Low-Density-Multiplexed-Assays--Next-Generation-Sequencing-Applications-Infectious-Disease-Diagnosis-Oncology-Autoimmune-Diseases-Cardiac-Allergies-and-Others---Global-Industry.html

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker